Denali Therapeutics Inc. (DNLI)

NASDAQ: DNLI · Real-Time Price · USD

13.95

-0.04 (-0.29%)

At close: Jul 1, 2025, 4:00 PM

14.37

+0.42 (3.01%)

After-hours: Jul 1, 2025, 6:31 PM EDT

Denali Therapeutics Market Cap

Denali Therapeutics has a market cap or net worth of $2.03 billion as of July 1, 2025. Its market cap has decreased by -35.76% in one year.

Market Cap

2.03B

Enterprise Value

1.02B

1-Year Change

-35.76%

Ranking

#1929

Market Cap Chart

Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $2.03B, an increase of 7.39%. That is a compound annual growth rate of 0.95%.

Market Cap History

Date	Market Cap	% Change
Jul 1, 2025	2.03B	-30.91%
Dec 31, 2024	2.93B	-1.10%
Dec 29, 2023	2.97B	-21.48%
Dec 30, 2022	3.78B	-30.66%
Dec 31, 2021	5.45B	-45.77%
Dec 31, 2020	10.04B	500.43%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	700.85B
Johnson & Johnson	366.31B
AbbVie	326.43B
Novo Nordisk	304.96B
UnitedHealth Group	279.26B
Novartis AG	235.85B
Abbott Laboratories	234.83B
AstraZeneca	217.42B

Market Cap Rankings